Iowa State University
Chemical and Biological Engineering
biomaterials and nanomedicine laboratories
  • Twitter
  • Home
  • People
    • Research Group
    • Group Alumni
  • Research
  • Publications/Patents
  • Lab Tour/Facilities
  • Collaborators
  • Funding
  • In the News

Funding

We are grateful to the federal and state government agencies, foundations, universities, and companies who have supported our research on nanovaccines, nanotherapeutics, and nanoparticles. Here is a current list of our recent sponsored projects.

Current Awards

Department of Defense (DOD)

“INNS: Integrated Neuroprotective and Neuroregenerative Strategies”
S Mallapragada, PI; A Kanthasamy, B Narasimhan, D Sakaguchi, Co-PIs     8/11–9/16

National Institutes of Health (NIH)

“Enhanced shelf-life nanovaccine formulation for immunity to biodefense pathogens”
B Narasimhan, PI; MJ Wannemuehler, BH Bellaire, TW Dubensky, and JM Hostetter, Co-PIs     9/14-8/18

National Science Foundation (NSF)

“REU Site: Biological Materials and Processes (BIOMAP)”
M Lamm, PI; B Narasimhan and others, Co-PI     2/16–2/19

U.S. Department of Agriculture (USDA)

“Next generation polyanhydride nanovaccine platform technology for poultry”
A Talaat, PI; B Narasimhan, Co-PI   5/16-4/19

“Nanoparticle delivery of antibiotics for disease control in cultured shrimp”
L Bartholomay, PI; B Narasimhan, B Bellaire, Co-PIs   5/15-4/18

 Universities

Iowa State University
“Presidential Initiative for Interdisciplinary Research: Systems Design of Nanovaccines”
B Narasimhan, PI; S Carpenter, M Wannemuehler, T Dubensky, R Silberglitt, Co-PIs    7/13–12/16

Recently Completed Awards

Department of Defense (DOD)

“Targeted Nanovaccine Platforms Against Respiratory Pathogens”
S Mallapragada, PI; S Carpenter, B Narasimhan, N Pohl, M Wannemuehler, Co-PIs     9/10–9/14

“Synthetic Nanovaccines Against Respiratory Pathogens”
S Mallapragada, PI; B Narasimhan, M Wannemuehler, Co-PIs     7/09–6/13

“Novel Therapies for Pneumonic Plague Targeting Quorum Sensing Components”
F Minion, PI; B Narasimhan, D Nordman, G Phillips, K Rajan, M Wannemuehler, Co-PIs     9/06–3/13

Health Resources and Services Administration

“INOVA: Interdisciplinary Laboratory for Design, Discovery, and Testing of Vaccines and Anti-Microbials”
B Narasimhan, PI; P Nara, M Wannemuehler, Co-PIs     8/10–12/14

National Institutes of Health (NIH)

“Enhancing B Cell Immunity Against HIV-1 Using Novel Vaccine Delivery Platforms”
M Cho, PI; B Narasimhan, N Pohl, N Greenspan, T Waldschmidt, K Knight, Co-PI     8/10–10/14

“Impact of Polymer Adjuvant Chemistry on Adaptive Immune Mechanisms”
B Narasimhan, PI; B Bellaire, M Wannemuehler, Co-PIs     8/10–6/13

National Science Foundation (NSF)

“A 21st Century Revitalized Research and Research Training Infrastructure for Chemical and Biological Engineering”
S Mallapragada, PI; R Fox, B Narasimhan, B Shanks, J Shanks, Co-PIs     10/10–9/13

“Molecular Design of Nano-carrier Materials for Reactions Catalyzed by Multi-Enzyme Complexes”
S Mallapragada, PI; B Narasimhan, R Peters, Co-PIs    10/09–9/13

“REU Site: Biological Materials and Processes”
B Narasimhan, PI; M Lamm, Co-PI     3/12–2/15

Foundations

Bill and Melinda Gates Foundation
“Combination Anti-Filarial Treatments Using Amphiphilic Micro- and Nanoparticles”
B Bellaire, PI; R Martin, B Narasimhan, Co-PIs     5/13–10/14

State of Iowa Regents Innovation Fund

Evaluation of α-synuclein immunotherapeutics in animal models of Parkinson’s disease
B Narasimhan, PI; V Anantharam and M John, Co-PIs     9/14-5/16

Back to the top

Balaji Narasimhan
2035 Sweeney Hall, Ames, Iowa 50011-2230
E-mail: nbalaji@iastate.edu
Office: 515-294-8019 • Fax: 515-294-2689
Copyright © 2025 · Iowa State University of Science and Technology. All rights reserved.